Is it safe to take melatonin?

Melatonin is now the fourth most commonly used dietary supplement among American adults—and for most healthy people, short-term use is well-supported by research. Across more than 79 randomized controlled trials involving over 3,800 participants, melatonin demonstrated a consistently favourable safety profile at standard doses, with adverse event rates comparable to placebo.^[1] But "generally safe" comes with important qualifications: dose, duration, your health profile, and supplement quality all matter significantly.

What the Clinical Evidence Actually Shows

The evidence base on melatonin safety is now substantial. Decades of randomized controlled trials consistently show that melatonin is well-tolerated at typical supplemental doses, with an adverse event profile that closely resembles placebo in blinded conditions. To understand why this is the case, it helps to recognize that unlike synthetic sleep medications, melatonin supplements a hormone your body already produces—which is a key reason its safety profile is fundamentally different. For a full explanation of the underlying biology, see our complete guide on what melatonin is and how it works.

A landmark meta-analysis examining controlled trials in primary sleep disorders found no statistically significant difference in adverse events between melatonin and placebo groups. The most commonly reported effects across included trials were headaches (13 events total), dizziness (10 events), nausea (3 events), and drowsiness (3 events)—none of which reached statistical significance compared to control.^[2]

A broader systematic review examined 50 controlled clinical studies of oral melatonin administration across multiple conditions. Of these, 26 found no statistically significant adverse events at all. The 24 studies that did report at least one significant adverse event characterized those events as "generally minor, short-lived and easily managed," with the most commonly flagged issues relating to fatigue, mood, or psychomotor performance.^[3]

For higher-dose melatonin (≥10 mg), a systematic review and meta-analysis of 79 randomized controlled trials involving 3,861 participants concluded that melatonin "appears to have a good safety profile" even at elevated doses, with no increase in serious adverse events relative to standard doses.^[1] Minor effects such as drowsiness, headache, and dizziness did increase in frequency at higher doses—an important reason why lower doses are preferable for most users.

One honest limitation: the majority of safety trials are short in duration, typically 12 weeks or less. Longer-term controlled data, while encouraging where it exists, has not yet been fully established through prospective clinical trials. This is addressed directly in the section on long-term use below.

Common Side Effects: What to Realistically Expect

Understanding melatonin's side effect profile accurately matters because people often overestimate or underestimate the risks. Our detailed guide to the bad side effects of melatonin covers the full clinical spectrum. Here we focus on what controlled safety studies specifically show.

The most consistently reported side effects in clinical trials include:

• Morning grogginess or daytime sleepiness: The most common complaint, reported in approximately 1.66% of melatonin users in controlled trials—at a rate not significantly different from placebo.^[4] This effect is strongly dose-dependent; higher doses (5–10 mg) produce more next-day sedation than lower doses (0.3–1 mg).
• Headache: Reported in approximately 0.74% of users versus placebo, typically mild and self-resolving.^[4]
• Dizziness: Also approximately 0.74%, and similarly transient in nature.^[4]
• Nausea: Infrequent and generally mild when it occurs.
• Vivid dreams or nightmares: Anecdotally common, though this is also reported with placebo in sleep trials, likely reflecting increased dream recall that accompanies improved sleep quality.

The NIH's National Center for Complementary and Integrative Health (NCCIH) notes that for doses higher than what the body normally produces, there is not yet a complete picture of overall safety effects.^[5] This is not a declaration that high-dose melatonin is harmful—it's an acknowledgement that absence of documented harm is not the same as confirmed safety at all dose levels.

One critically important point: melatonin is not habit-forming. Unlike benzodiazepines or Z-drugs, it does not cause physical dependence, withdrawal symptoms, or rebound insomnia upon discontinuation. This aspect of its profile is one of its most clinically meaningful advantages over prescription sleep aids. For the detailed evidence, see our article on melatonin tolerance and long-term dependency.

Is Melatonin Safe for Long-Term Use?

This is where honest science requires nuance. The majority of melatonin safety trials are short-term, typically under 12 weeks, which means the long-term safety picture has not been fully established by prospective controlled research. That said, the evidence we do have is largely reassuring.

A 2023 narrative review of chronic melatonin administration concluded that "melatonin at low to moderate dosages (approximately 5–6 mg daily or less) appears safe" and noted that research on long-term administration generally finds no difference from placebo on negative outcome measures.^[6] Long-term use has even shown potential benefits in certain patient populations, particularly those with autism spectrum disorder and neurodegenerative conditions.

One legitimate concern about extended use is whether supplemental melatonin might suppress the body's own production. Current evidence says the effect is minimal and quickly reversible. Multiple studies show that natural melatonin production returns to baseline within one to three days of stopping supplementation, with no evidence that months of use permanently alters pineal gland output—a meaningful contrast with hormones like testosterone or thyroid hormone that have strong negative feedback loops.

The practical guidance most clinicians follow: short-term melatonin use up to 1–2 months is well-supported by evidence. For ongoing or indefinite use, periodic reassessment with a healthcare provider is advisable, particularly to ensure you're using the lowest effective dose and that supplementation remains appropriate for your circumstances. This consideration becomes especially important for the higher-caution population groups described in the next section.

Who Should Be Cautious: Special Populations

Melatonin's safety profile is not uniform across all groups. For certain individuals—and for people wondering who should take melatonin in the first place—additional caution or medical supervision is warranted.

Pregnant and Breastfeeding Women

Melatonin supplementation during pregnancy has not been adequately studied in clinical safety trials. A 2022 scoping review of 15 human studies found no major adverse events reported in the clinical literature, but the authors were careful to note that the absence of reported harm does not confirm safety—animal studies have raised concerns at high doses.^[7] The NIH's LactMed database notes that short-term evening use is unlikely to harm a breastfed infant, but recommends monitoring the baby for unusual sleepiness.^[8] Standard guidance: consult a healthcare provider before using melatonin while pregnant or nursing.

Children and Adolescents

Pediatric melatonin use has grown dramatically, but regulatory and clinical guidance remains cautious. A 2023 systematic review and GRADE assessment found that melatonin does not statistically increase serious adverse events in children; however, safety data in controlled trials was scarce—fewer than half of the included studies reported on adverse events, and none provided comprehensive data on long-term effects on puberty or bone health.^[9] The NCCIH specifically flags uncertainty about melatonin's effects on hormonal development in children and adolescents.^[5] The CDC estimated 11,000 emergency department visits between 2019 and 2022 from children aged 5 and younger accidentally ingesting melatonin—primarily gummy products—underscoring the importance of secure storage. Medical supervision is strongly recommended before giving melatonin to any child.

Older Adults

Older adults often respond more strongly to melatonin because of increased receptor sensitivity, even as natural production declines with age. Doses of 0.3–1 mg are typically more appropriate for adults over 65 than the standard 3–10 mg products found in most stores. The NIH recommends adults over 65 speak with a doctor before taking melatonin supplements, and a 2023 review confirms that while adverse effects in this population are minor, most trials are too short-term to fully characterize longer-duration risks.^[4]

People on Medications

Melatonin has documented interactions with several important drug classes, including blood thinners (warfarin), antidepressants (SSRIs, MAOIs), immunosuppressants, diabetes medications, and antiepileptic drugs. Our melatonin drug interactions guide covers each category in clinical detail. If you are on any prescription medication, reviewing potential interactions with your pharmacist or physician before adding melatonin is essential.

Dose and Safety: Why Less Is Usually More

One of the most important—and most underappreciated—safety points about melatonin: the doses sold in most stores are far higher than what research shows is necessary, and higher doses do not produce better sleep outcomes. They do, however, produce more side effects.

Standard over-the-counter melatonin in North America typically comes in 3 mg, 5 mg, or 10 mg tablets. Yet research consistently shows that doses as low as 0.3 mg can be as effective for sleep onset in many people as doses 10–30 times higher.^[11] Melatonin's sleep-promoting effect plateaus once receptors are saturated—adding more hormone beyond this point doesn't improve outcomes but does increase the likelihood of morning grogginess, vivid dreams, and circadian disruption.

Our complete melatonin dosage guide walks through the dose-response evidence in detail. The practical takeaway: start at the lowest effective dose (0.5–1 mg) and only increase if needed, staying at or below 5 mg for most adult use cases.

One nuance worth understanding for safety purposes: standard oral melatonin undergoes extensive first-pass liver metabolism. StatPearls cites 90% hepatic extraction via CYP1A2 enzymes for conventional oral tablets.^[11] This means the systemic dose reaching your bloodstream from a typical 5 mg tablet is roughly 0.5–1 mg—which is why many people have been unknowingly taking physiological doses far lower than the label suggests, and also why people exceeding 10 mg are often not generating the risk the number might imply. It does, however, explain why delivery method matters so much for both predictability and safety.

Supplement Quality and Its Safety Implications

Here is a safety issue that receives far less attention than it deserves: the melatonin you purchase may not contain what the label states. Unlike prescription medications, dietary supplements in the United States are not subject to pre-market FDA approval. Manufacturers bear responsibility for labelling accuracy, but without pre-market third-party verification requirements.

The consequences of this regulatory gap are well-documented. A 2023 study examining over-the-counter melatonin gummies found that 22 of 25 products tested (88%) were inaccurately labelled, with actual melatonin content ranging from 74% to 347% of the stated dose. Several products also contained undisclosed serotonin contamination—a clinically meaningful finding for anyone using antidepressants or other serotonergic medications.

For any consumer, but especially for children and older adults, this labelling variability creates a practical safety problem. A product delivering 3.5 times the expected dose produces grogginess, vivid dreams, and potential circadian disruption that the user cannot explain or predict. Conversely, a product delivering less than stated may simply fail to work—leading to dose escalation and further unpredictability.

The solution is straightforward: choose supplements manufactured under GMP-certified conditions and verified by independent third-party testing, with a current Certificate of Analysis (COA) confirming potency and purity. Our guide to choosing quality melatonin covers exactly what to look for—and what red flags to avoid.

Why Bioavailability Matters for Safe and Effective Melatonin Use

Safe melatonin use is not only about the dose on the label—it's about the dose that actually reaches your bloodstream. As the StatPearls data makes clear, standard oral tablets lose approximately 90% of their melatonin to first-pass liver metabolism before reaching circulation. This creates an inherently imprecise delivery system where the relationship between "label dose" and "systemic dose" is difficult to predict across different products and individuals.

BioAbsorb Nutraceuticals developed their Liposomal Liquid Melatonin specifically to address this gap. Using pharmaceutical-grade liposomal encapsulation technology, the melatonin is protected from gastrointestinal degradation and hepatic first-pass metabolism—achieving 80–95% bioavailability compared to the 10–15% typical of standard tablets. Each full dropper (1 mL) delivers 5 mg with a precision-adjustable dose that allows incremental titration, unlike tablets or gummies where the dose is fixed by the manufacturer.

From a safety standpoint, this matters practically in two ways. First, higher bioavailability means a significantly lower label dose is needed to achieve the same systemic effect as a much larger tablet dose—reducing unnecessary ingredient load and the risk of overshooting your effective dose. Second, the liquid dropper format addresses the labelling accuracy problem that affects most gummies and tablets. You can see and adjust exactly what you are administering, with no compression fillers, no undisclosed additives, and no batch-to-batch variation hiding behind the label.

BioAbsorb's melatonin is manufactured under GMP-certified conditions with third-party testing for both potency and purity. For consumers who want the most predictable, evidence-aligned, and dose-controllable melatonin option available, liposomal liquid delivery represents the current standard.

Frequently Asked Questions

Can you take melatonin every night?

Nightly use for up to 1–2 months is well-supported for most healthy adults. For longer ongoing use, periodic reassessment with a healthcare provider is advisable to ensure continued appropriateness and to confirm you are still using the lowest effective dose. Melatonin does not cause physical dependence and does not require tapering when you decide to stop—unlike many prescription sleep medications.

Is melatonin safe to take with other medications?

This depends substantially on what you are taking. Melatonin has well-documented interactions with anticoagulants (warfarin), antidepressants, immunosuppressants, antiepileptics, and diabetes medications—among others. It also interacts with alcohol and caffeine. If you are on any prescription medication, review potential interactions with your pharmacist or physician before adding melatonin. Our complete drug interactions guide covers the key pairings and their mechanisms in detail.

What happens if you take too much melatonin?

An acute melatonin overdose in healthy adults is unlikely to be life-threatening, but excessive doses—particularly above 10–30 mg—are associated with pronounced next-day grogginess, dizziness, nausea, and vivid dreams. The more significant overdose concern involves children accidentally ingesting flavoured gummy products; the CDC documented 11,000 emergency department visits between 2019 and 2022 from unsupervised ingestion by children aged 5 and younger. Keep all melatonin products stored securely. If overdose is suspected, contact Poison Control at 1-800-222-1222.

Is melatonin safe for older adults?

Older adults often respond more strongly to melatonin because receptor sensitivity increases with age, even as natural production declines. Doses of 0.3–1 mg are typically more appropriate for adults over 65 than the standard 3–10 mg products found in most retail settings, where higher doses are likely to produce more side effects without additional sleep benefit. Adults over 65 should speak with a doctor before starting any melatonin supplementation, and should also review potential medication interactions, which become more complex in older populations managing multiple prescriptions.

Is melatonin safe during pregnancy?

The evidence base on melatonin safety during pregnancy remains insufficient to make a confident recommendation either way. No major adverse events have been reported in available human clinical studies, but trials specifically designed to evaluate pregnancy safety are lacking. It is worth noting that endogenous melatonin levels are naturally elevated during pregnancy—particularly in the third trimester—but the effect of adding supplemental melatonin on top of this has not been adequately studied. Standard clinical guidance is to avoid supplemental melatonin during pregnancy unless specifically directed by a healthcare provider.

Conclusion

For most healthy adults taking appropriate doses for short periods, melatonin is safe and well-tolerated—a conclusion supported by decades of controlled clinical trials. The side effects that do occur are typically mild, transient, and comparable to placebo in blinded studies. Where genuine caution is warranted—special populations, drug interactions, long-term use above 5–6 mg, and supplement quality—the data guides specific, actionable steps rather than a blanket warning.

If you are considering melatonin for the first time: start with the lowest effective dose, choose a third-party verified product with confirmed potency, and consult your healthcare provider if you fall into one of the higher-caution categories above. Sleep well—and safely.

Shop BioAbsorb Liposomal Melatonin →

Research References

1. Vo TT, et al. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. [Journal details to verify] 2021. PubMed: 34923676
2. Buscemi N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders: A meta-analysis. [Journal details to verify] 2005. PMC: PMC1490287
3. Besag FMCA, et al. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. [Journal details to verify] 2019. PubMed: 30670284
4. Tuft C, Matar E, Schrire ZM, et al. Current insights into the risks of using melatonin as a treatment for sleep disorders in older adults. Clin Interv Aging. 2023;18:1849–1859. PMC: PMC9842516
5. National Center for Complementary and Integrative Health (NCCIH). Melatonin: What You Need to Know. National Institutes of Health. nccih.nih.gov
6. Savage R, Mayeux R. Chronic Administration of Melatonin: Physiological and Clinical Considerations. [Journal details to verify] 2023. PMC: PMC10053496
7. Vine T, Brown GM, Frey BN. Melatonin use during pregnancy and lactation: A scoping review of human studies. [Journal details to verify] 2022. PMC: PMC9169489
8. National Institutes of Health. Melatonin — Drugs and Lactation Database (LactMed). ncbi.nlm.nih.gov/books/NBK501863
9. Engstrand S, et al. The short-term and long-term adverse effects of melatonin treatment in children and adolescents: A systematic review and GRADE assessment. [Journal details to verify] 2023. PubMed: 37483551
10. Canadian Agency for Drugs and Technologies in Health (CADTH). Melatonin for the Treatment of Insomnia: A 2022 Update. NCBI Bookshelf. ncbi.nlm.nih.gov/books/NBK605080
11. Savage RA, Zafar N, Yohannan S, Miller JM. Melatonin. StatPearls. Updated 2024. ncbi.nlm.nih.gov/books/NBK534823
12. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE. 2013;8(5):e63773. PubMed: 23691095
13. Andersen LPH, Gögenur I, Rosenberg J, Reiter RJ. The safety of melatonin in humans. Clin Drug Investig. 2016;36(3):169–175. PubMed: 26692007
14. BioAbsorb Nutraceuticals. What Is Melatonin? Complete Guide to How This Sleep Hormone Works. bioabsorbnutraceuticals.com
15. BioAbsorb Nutraceuticals. What Are the Bad Side Effects of Melatonin? bioabsorbnutraceuticals.com

---

About the Author
David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, are pregnant or nursing, or are considering melatonin for a child. Individual responses to melatonin vary significantly, and what is appropriate for one person may not be appropriate for another.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.